Form 4: ImmuCell Director Tomsche Acquires Additional Shares
SEC Form 4 Filing
Director David Scott Tomsche acquired 6,005 shares of ImmuCell Corp common stock at $3.55 per share on August 23, 2024.
Summary
- On August 23, 2024, David Scott Tomsche, a director of ImmuCell Corp, purchased 6,005 shares of the company's common stock.
- The purchase price was $3.55 per share.
- Following the transaction, Tomsche directly owns 129,611 shares of ImmuCell Corp, which includes 6,987 shares held by immediate family members.
- The transaction was reported on August 26, 2024.
Sentiment
Score: 6
Explanation: Insider buying is generally viewed as a positive sign, suggesting confidence in the company's prospects, but this is a relatively small transaction.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This is a routine disclosure of insider trading activity. It doesn't provide specific insight into ImmuCell's competitive positioning or broader industry trends.
Stakeholder Impact
- The purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/23/2024 | Date of transaction: David Scott Tomsche acquired 6,005 shares of ImmuCell Corp common stock. |
| 08/26/2024 | Date of report filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.